The impact of anti-cyclic citrullinated peptide antibody status on the management of patients with early rheumatoid arthritis: observational study results from Lithuania

por Stropuvienė, Sigita, Baranauskaitė, Asta, Bukauskienė, Loreta, Zaikauskienė, Jolanta
Publicado 2018

Nurse’s Role from Medical Students’ Perspective during Their Interprofessional Clinical Practice: Evidence from Lithuania

por Blaževičienė, Aurelija, Vanckavičienė, Aurika, Paukštaitiene, Renata, Baranauskaitė, Asta
Publicado 2021

An optimal ultrasonographic diagnostic test for early gout: A prospective controlled study

por Norkuviene, Eleonora, Petraitis, Mykolas, Apanaviciene, Indre, Virviciute, Dalia, Baranauskaite, Asta
Publicado 2017

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study

por Baranauskaite, Asta, Raffayová, Helena, Kungurov, NV, Kubanova, Anna, Venalis, Algirdas, Helmle, Laszlo, Srinivasan, Shankar, Nasonov, Evgeny, Vastesaeger, Nathan
Publicado 2011

Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis: Fifty‐Two–Week Phase III Randomized Study Results

por Weinblatt, Michael E., Baranauskaite, Asta, Dokoupilova, Eva, Zielinska, Agnieszka, Jaworski, Janusz, Racewicz, Artur, Pileckyte, Margarita, Jedrychowicz‐Rosiak, Krystyna, Baek, Inyoung, Ghil, Jeehoon
Publicado 2018

Rapid improvement in spinal pain in patients with axial spondyloarthritis treated with secukinumab: primary results from a randomized controlled phase-IIIb trial

por Poddubnyy, Denis, Pournara, Effie, Zielińska, Agnieszka, Baranauskaite, Asta, Jiménez, Alejandro Muñoz, Sadhu, Sanchayita, Schulz, Barbara, Rissler, Michael, Perella, Chiara, Marzo-Ortega, Helena
Publicado 2021

A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy

por Emery, Paul, Vencovský, Jiří, Sylwestrzak, Anna, Leszczyński, Piotr, Porawska, Wieslawa, Baranauskaite, Asta, Tseluyko, Vira, Zhdan, Vyacheslav M, Stasiuk, Barbara, Milasiene, Roma, Barrera Rodriguez, Aaron Alejandro, Cheong, Soo Yeon, Ghil, Jeehoon
Publicado 2017

52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis

por Emery, Paul, Vencovský, Jiří, Sylwestrzak, Anna, Leszczyński, Piotr, Porawska, Wieslawa, Baranauskaite, Asta, Tseluyko, Vira, Zhdan, Vyacheslav M., Stasiuk, Barbara, Milasiene, Roma, Barrera Rodriguez, Aaron Alejandro, Cheong, Soo Yeon, Ghil, Jeehoon
Publicado 2017

Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a ph...

por Pavelka, Karel, Szekanecz, Zoltán, Damjanov, Nemanja, Anić, Branimir, Tomšič, Matija, Mazurov, Vadim, Maksimovic, Marija, Nagy, Orsolya, Świerkot, Jerzy, Petranova, Tzvetanka, Veldi, Tiina, Baranauskaitė, Asta, Codreanu, Catalin, Andersone, Daina, Fleischmann, Roy
Publicado 2020

Musculoskeletal ultrasonography in routine rheumatology practice: data from Central and Eastern European countries

por Mandl, Peter, Baranauskaite, Asta, Damjanov, Nemanja, Hojnik, Maja, Kurucz, Reka, Nagy, Orsolya, Nemec, Petr, Niedermayer, Dora, Perić, Porin, Petranova, Tzvetanka, Pille, Andres, Rednic, Simona, Vlad, Violeta, Zlnay, Martin, Balint, Peter V.
Publicado 2016

A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the...

por Yoo, Dae Hyun, Racewicz, Artur, Brzezicki, Jan, Yatsyshyn, Roman, Arteaga, Edgardo Tobias, Baranauskaite, Asta, Abud-Mendoza, Carlos, Navarra, Sandra, Kadinov, Vladimir, Sariego, Irmgadt Goecke, Hong, Seung Suh, Lee, Sung Young, Park, Won
Publicado 2016

A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid art...

por Choe, Jung-Yoon, Prodanovic, Nenad, Niebrzydowski, Jaroslaw, Staykov, Ivan, Dokoupilova, Eva, Baranauskaite, Asta, Yatsyshyn, Roman, Mekic, Mevludin, Porawska, Wieskawa, Ciferska, Hana, Jedrychowicz-Rosiak, Krystyna, Zielinska, Agnieszka, Choi, Jasmine, Rho, Young Hee, Smolen, Josef S
Publicado 2017

Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results

por Smolen, Josef S., Choe, Jung-Yoon, Prodanovic, Nenad, Niebrzydowski, Jaroslaw, Staykov, Ivan, Dokoupilova, Eva, Baranauskaite, Asta, Yatsyshyn, Roman, Mekic, Mevludin, Porawska, Wieskawa, Ciferska, Hana, Jedrychowicz-Rosiak, Krystyna, Zielinska, Agnieszka, Choi, Jasmine, Rho, Young Hee
Publicado 2017

Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid ar...

por Smolen, Josef S, Choe, Jung-Yoon, Prodanovic, Nenad, Niebrzydowski, Jaroslaw, Staykov, Ivan, Dokoupilova, Eva, Baranauskaite, Asta, Yatsyshyn, Roman, Mekic, Mevludin, Porawska, Wieslawa, Ciferska, Hana, Jedrychowicz-Rosiak, Krystyna, Zielinska, Agnieszka, Lee, Younju, Rho, Young Hee
Publicado 2018

Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13...

por Yoo, Dae Hyun, Prodanovic, Nenad, Jaworski, Janusz, Miranda, Pedro, Ramiterre, Edgar, Lanzon, Allan, Baranauskaite, Asta, Wiland, Piotr, Abud-Mendoza, Carlos, Oparanov, Boycho, Smiyan, Svitlana, Kim, HoUng, Lee, Sang Joon, Kim, SuYeon, Park, Won
Publicado 2017

Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study

por Sokka, Tuulikki, Toloza, Sergio, Cutolo, Maurizio, Kautiainen, Hannu, Makinen, Heidi, Gogus, Feride, Skakic, Vlado, Badsha, Humeira, Peets, Tõnu, Baranauskaite, Asta, Géher, Pál, Újfalussy, Ilona, Skopouli, Fotini N, Mavrommati, Maria, Alten, Rieke, Pohl, Christof, Sibilia, Jean, Stancati, Andrea, Salaffi, Fausto, Romanowski, Wojciech, Zarowny-Wierzbinska, Danuta, Henrohn, Dan, Bresnihan, Barry, Minnock, Patricia, Knudsen, Lene Surland, Jacobs, Johannes WG, Calvo-Alen, Jaime, Lazovskis, Juris, Pinheiro, Geraldo da Rocha Castelar, Karateev, Dmitry, Andersone, Daina, Rexhepi, Sylejman, Yazici, Yusuf, Pincus, Theodore
Publicado 2009

Phase III Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate‐to‐Severe Rheumatoid Arthritis

por Weinblatt, Michael E., Baranauskaite, Asta, Niebrzydowski, Jaroslaw, Dokoupilova, Eva, Zielinska, Agnieszka, Jaworski, Janusz, Racewicz, Artur, Pileckyte, Margarita, Jedrychowicz‐Rosiak, Krystyna, Cheong, Soo Yeon, Ghil, Jeehoon, Sokolovic, S., Mekic, M., Prodanovic, N., Gajic, B., Karaselimovic‐Dzambasovic, E., Pojskic, B., Toncheva, A., Dimitar, P., Rodina, L., Geneva‐Popova, M., Staykov, I., Stoilov, R., Podrazilova, L., Mosterova, Z., Simkova, G., Kopackova, J., Stejfova, Z., Vencovsky, J., Urbanova, Z., Janska, L., Galatíkova, D., Stropuviene, S., Sniuoliene, I., Sitek‐Ziolkowska, K., Rell‐Bakalarska, M., Kolasa, R., Daniluk, S., Sliwowska, B., Bartosik‐Twardowska, M., Brzezicki, J., Konieczny, M., Jeka, S., Choe, J., Bae, S., Kang, Y., Prystupa, L., Vyacheslav, Z., Gasanov, I., Yatsyshyn, R., Rekalov, D., Iaremenko, O., Stanislavchuk, M., Tseluyko, V.
Publicado 2017